Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2007
11/08/2007CA2650704A1 Salts of pyridazine compounds
11/08/2007CA2650683A1 Amine derivative having npy y5 receptor antagonist activity
11/08/2007CA2650625A1 Formulations containing pyridazine compounds for treating neuroinflammatory diseases
11/08/2007CA2650383A1 Diazeniumdiolated non-steroidal anti-inflammatory drugs, compositions thereof, and related methods
11/08/2007CA2650382A1 Diketo-piperazine and piperidine derivatives as antiviral agents
11/08/2007CA2649995A1 Amino-ethyl-amino-aryl (aeaa) compounds and their use
11/08/2007CA2649111A1 Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007CA2648124A1 Kinase inhibitors
11/08/2007CA2648019A1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007CA2647949A1 P38 inhibitors and methods of use thereof
11/07/2007EP1852432A1 Nitrogenous heterocyclic compound and medicinal use thereof
11/07/2007EP1851209A2 [1,2,4]-dithiazoli(di)ne derivatives, inducers of gluthathione-s-transferase and nadph quinone oxido-reductase, for prophylaxis and treatment of adverse conditions associated with cytotoxicity in general and apoptosis in particular
11/07/2007EP1851204A1 Naphthalene derivatives as modulators of the glucocorticoid receptor
11/07/2007EP1539712B1 Pyrimidine derivatives and their use as cb2 modulators
11/07/2007EP1165523B1 Neurotrophic substituted pyrimidines
11/07/2007CN101068808A 1-[(6,7-substituted alkoxyquinoxalinyl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives
11/07/2007CN101068807A Method for production of candesartan
11/07/2007CN101068794A Quinazolines useful as modulators of ion channels
11/07/2007CN101068772A N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
11/07/2007CN101068595A Cgrp受体拮抗剂 Cgrp receptor antagonists
11/07/2007CN101066968A Prepn process of alizapride hydrochloride
11/07/2007CN100347160C Quinolin-, isoquinolin-, and quinazolin-oxyalkylamides and their use as fungicides
11/07/2007CN100346786C Substituted benzimidazole compounds and their use for the treatment of cancer
11/06/2007US7291729 Reacting 2,3,4-trifluoronitrobenzene with an alkali metal aryloxide, contacting the 3,4-difluoro-2-aryloxynitrobenzene produced with an alkali metal salt of a malonate diester to replace the 4-fluoro group with the malonate; optional further hydrolysis, reduction of the NO2 group, and decarboxylation
11/06/2007US7291641 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
11/06/2007US7291640 Substituted triazole derivatives as oxytocin antagonists
11/06/2007US7291624 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders
11/06/2007US7291622 Administering a 4-Amino-2-[1-(o-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinylcarbamate derivative, optionally mixed with an organic nitrate or NO donor or a cGMP inhibitor for treating sexual dysfunction
11/06/2007US7291619 Melanocortin receptor agonists
11/06/2007US7291618 (3,3-Difluoropyrrolidin-1-yl)-((2S,4S)-4-(4-(pyrimidin-2-yl) piperazin-1-yl)pyrrolidin-2-yl)methanone, usedin treating diabetic complications including diabetic neuropathy, diabetic nephropathy, diabetic microangiopathy, and the like.
11/06/2007US7291616 Such as 6(5-chloro-2-methoxyphenyl)-N-(4-chlorophenyl)-(1,3,5) triazine-2,4-diamine for inhibition of lysophosphatidic acid acyltransferase (LLPAAT-SS); antitumor agents
11/06/2007US7291613 Inhibitors of p38 kinase
11/06/2007US7291293 Chromophore comprising pyrimidin-2,4,6-trione and/or pyrrolidinedione/2,5-/ derivative with diaminomelamine or aminopurinone groups; quality, thickness; electrooptic films; acentric microstructure
11/06/2007CA2263927C Heterocyclic thioesters and ketones
11/01/2007WO2007124337A1 Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1
11/01/2007WO2007124329A1 Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/01/2007WO2007124318A1 Inhibitors of c-fms kinase
11/01/2007WO2007124316A1 Heterocyclic compounds as inhibitors of c-fms kinase
11/01/2007WO2007124288A1 Indazole compounds and methods for inhibition of cdc7
11/01/2007WO2007123953A2 Phosphodiesterase 4 inhibitors
11/01/2007WO2007123936A1 Novel heteroaryl-substituted arylaminopyridine derivatives as mek inhibitors
11/01/2007WO2007123855A2 Pyrazolines for controlling invertebrate pests
11/01/2007WO2007123516A1 C-fms kinase inhibitors
11/01/2007WO2007123277A1 Novel process for production of pyrimidine compound
11/01/2007WO2007122812A1 Therapeutic agent for inflammatory bowel disease
11/01/2007WO2007122508A2 An improved process for the preparation of irbesartan
11/01/2007WO2007122482A1 Fused phenyl amido heterocyclic compounds for the prevention and treatment of glucokinase-mediated diseases
11/01/2007WO2007122340A1 Cationic dichromophoric compound containing two units of hydrazone type and comprising a cationic linker arm, dye composition comprising at least one such compound, method for the use thereof and uses
11/01/2007WO2007122219A1 3- (aminomethyliden) 2-indolinone derivatives and their use as cell proliferation inhibitors
11/01/2007WO2007122173A1 Substituted pyrazinone derivatives for use as a medicine
11/01/2007WO2007122165A1 Novel compounds
11/01/2007WO2007122156A1 2-substituted 4-benzylphthalazinone derivatives as histamine h1 and h3 antagonists
11/01/2007WO2007122103A1 Diazepan derivatives modulators of chemokine receptors
11/01/2007WO2007121687A1 4-methyl-1h-diaryl pyrazole derivatives and their uses as medicament
11/01/2007WO2007108936A3 N-substituted-azacyclylamines as histamine-3 antagonists
11/01/2007WO2007095124A3 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors
11/01/2007WO2007083096A3 N- (2, 3-difluorophenyl) -2- [4- ( {7-methoxy-5- [ (2r) -piperidin. -2-ylmethoxy] quinazoli n-4-yl}amino) -lh-pyrazol-1-yl] acetamide and n- (2, 3 -d i fluoro phenyl) -2- [4- ( {7-ethoxy-5- [ (2r) -piperidin. -2-ylmethoxy] quinazolin
11/01/2007WO2007062376A3 Selective inhibition of matrix metalloproteinases
11/01/2007WO2007047351A3 Methods for treating hypertension in overweight and obese individuals
11/01/2007WO2007047146A3 Inhibitors of viral replication
11/01/2007WO2007002157A3 Process for preparing benzimidazole compounds
11/01/2007US20070254935 Pyrazole and imidazole compounds and uses thereof
11/01/2007US20070254920 Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use
11/01/2007US20070254913 3-Ethyl-6-(1-ethyl-1H-pyrazol-5-yl)-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridine; adenosine monophosphate activator; antiinflammatory agent, antidepressant, antiallergen, cognition activator, neurodegenerative diseases; arthritis, Alzheimer's disease, schizophrenia, Parkinson disease
11/01/2007US20070254881 Pyrazole Derivative
11/01/2007US20070254877 Indole Derivative and Use for Treatment of Cancer
11/01/2007US20070254870 3-Benzyl-7-chloro-2-[2-methyl-1-(7-oxo-[1,4]diazepan-1-yl)-propyl]-3H-quinazolin-4-one; mitotic kinesin KSP inhibitors; dysfunction of mitotic spindle, resulting in cell cycle arrest and cell death; anticarcinogenic, antiinflammatory, antiproliferative agents
11/01/2007US20070254869 modulators of Cholesterol ester transfer protein activity, such as 5-[Acetyl-(3,5-bis-trifluoromethyl-benzyl)-amino]-7-trifluoromethyl-2,3,4,5-tetrahydro-benzo[b]azepine-1-carboxylic acid isopropyl ester, for treating or preventing cardiovascular disorders
11/01/2007US20070254868 such as 3-(1-(2,3-difluorophenyl)-1H-tetrazol-5-yl)-5-(4-(4-methylpiperazin-1-yl) phenyl)pyridin-2-amine, used as anticarcinogenic agents or for the treatment of atherosclerosis and lung fibrosis
11/01/2007US20070254867 Heterocyclic Kinase Inhibitors
11/01/2007US20070254363 Substituted biaryl compounds for inflammation and immune-related uses
11/01/2007CA2649919A1 Phenyl-and pyridinyl amide inhibitors of c-fms kinase
11/01/2007CA2649736A1 Heterocyclic compounds as inhibitors of c-fms kinase
11/01/2007CA2649636A1 Diazepan derivatives modulators of chemokine receptors
11/01/2007CA2649512A1 C-fms kinase inhibitors
11/01/2007CA2649509A1 Novel compounds
11/01/2007CA2649256A1 Therapeutic agent for inflammatory bowel disease
11/01/2007CA2649029A1 2-substituted 4-benzylphthalazinone derivatives as histamine h1 and h3 antagonists
11/01/2007CA2648809A1 Indazole compounds and methods for inhibition of cdc7
11/01/2007CA2647677A1 Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/01/2007CA2646678A1 Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/01/2007CA2646652A1 Substituted pyrazinone derivatives for use as a medicine
11/01/2007CA2646638A1 3- (aminomethyliden) 2-indolinone derivatives and their use as cell proliferation inhibitors
11/01/2007CA2644425A1 Novel heteroaryl-substituted arylaminopyridine derivatives as mek inhibitors
10/2007
10/31/2007EP1849784A1 Indoline-substituted pyrazoline compounds, their preparation and use as medicaments
10/31/2007EP1849783A1 Octahydropentalene-substituted pyrazoline compounds, their preparation and use as medicaments
10/31/2007EP1849782A1 Quinolinone derivatives as tyrosine kinase inhibitors
10/31/2007EP1848711A1 Fungicidal pyrazine derivatives
10/31/2007EP1848694A1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1
10/31/2007EP1848692A1 AZOLYLACYLGUANIDINES AS ß-SECRETASE INHIBITORS
10/31/2007EP1848435A2 Compounds for inflammation and immune-related uses
10/31/2007EP1848428A2 Thiazole amides, imidazole amides and related analogues
10/31/2007EP1513821B1 Protein kinase inhibitors
10/31/2007EP1496896A4 Inhibitors of akt activity
10/31/2007EP1448551B1 Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth
10/31/2007EP1318980B1 Hydroxamate derivatives useful as deacetylase inhibitors
10/31/2007EP1144384B1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/31/2007CN101065364A Novel pyrimidine derivatives and their use as PPAR-alpha modulators
10/31/2007CN101065363A Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
10/31/2007CN101065361A Bengamides with a substituted caprolactame cycle, method forthe preparation thereof, compositions containing them and use thereof
1 ... 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 ... 626